+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Food Allergy Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 180 Pages
  • February 2024
  • Region: Global
  • Expert Market Research
  • ID: 5941098

Food Allergy Market Outlook

The food allergy market size was valued at USD 39.03 billion in 2023, driven by rising prevalence of food allergies across the world. The market size is anticipated to grow at a CAGR of 5.4 % during the forecast period of 2024-2032 to achieve a value of USD 62.7 billion by 2032.

Food Allergy: Introduction

A food allergy is an adverse immune response that occurs when the body mistakenly identifies a certain food protein as harmful, triggering a protective reaction. Symptoms can range from mild (such as hives, itching, or gastrointestinal discomfort) to severe and potentially life-threatening (like anaphylaxis, characterized by difficulty breathing, a drop in blood pressure, and dizziness). Common allergenic foods include nuts, milk, eggs, shellfish, and wheat. Management typically involves avoiding the allergenic food and having emergency medication like epinephrine accessible.

Key Trends in the Food Allergy Market

There is a rising prevalence of food allergies globally, driving demand for diagnostic and therapeutic options. Improved diagnostic methods, including more accurate and rapid testing kits, are being developed to identify food allergies with greater precision.

There's an increasing focus on developing and approving new treatments, such as oral immunotherapy, to desensitize individuals to allergens. Greater public and healthcare professional awareness about food allergies is leading to earlier diagnosis and better management.

The growth of the 'free-from' market, including gluten-free, nut-free, and dairy-free products, is significant, catering to those with food allergies. Stricter labelling laws and regulations globally are improving safety and transparency for consumers with food allergies.

Increase in allergy-friendly dining options and food services in schools, restaurants, and public spaces to accommodate individuals with food allergies.

Use of mobile apps and online resources for allergy management, including allergen tracking and emergency response, is on the rise.

Food Allergy Market Segmentation

Market Breakup by Food Source

  • Dairy Products
  • Poultry Product
  • Tree Nuts
  • Peanuts
  • Shellfish
  • Wheat
  • Soy
  • Others

Market Breakup by Symptoms

  • Anaphylaxis
  • Atopic Dermatitis
  • Others

Market Breakup by Diagnosis Test

  • Skin-Prick Tests
  • Blood Test
  • Elimination Diet
  • Oral Food Challenge
  • Others

Market Breakup by Treatment Type

  • Epinephrine
  • Oral Immunotherapy
  • Antihistamines
  • Others

Market Breakup by Region

  • United States
  • EU-4 and the United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan

Food Allergy Market Overview

In North America, the food allergy market is witnessing growth in allergy diagnostics and therapeutics, driven by high awareness and advanced healthcare infrastructure. There's a strong emphasis on food labeling regulations, ensuring allergen-free options are available and clearly marked. The region also sees significant research into allergy treatments, including oral immunotherapy, alongside a growing trend in allergy-friendly food products, catering to the needs of individuals with food allergies.

Europe's food allergy market is marked by stringent food safety regulations and a focus on consumer protection, with clear labeling of potential allergens in food products being a priority. The region is also witnessing growth in allergy diagnostics and an increasing prevalence of food allergies, driving the demand for specialized healthcare services. European countries are actively involved in research to understand food allergy mechanisms and develop novel treatment approaches.

Japan is experiencing a rise in food allergy awareness and diagnosis, particularly in urban areas and among the middle class. Changing dietary patterns and the introduction of western diets may be contributing to an increased incidence of food allergies.

Food Allergy Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Mylan N.V.
  • Teva Pharmaceutical Industries
  • Sanofi
  • Boehringer Ingelheim International GmbH
  • AstraZeneca
  • Johnson & Johnson Private Limited
  • Bayer AG


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Food Allergy Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Food Allergy Epidemiology Analysis - 7MM
5.1 7MM Epidemiology Scenario Overview (2017-2032)
5.2 United States Food Allergy Epidemiology Forecast (2017-2032)
5.3 EU-4 and United Kingdom Food Allergy Epidemiology Forecast (2017-2032)
5.3.1 Germany Food Allergy Epidemiology Forecast (2017-2032)
5.3.2 France Food Allergy Epidemiology Forecast (2017-2032)
5.3.3 Italy Food Allergy Epidemiology Forecast (2017-2032)
5.3.4 Spain Food Allergy Epidemiology Forecast (2017-2032)
5.3.5 United Kingdom Food Allergy Epidemiology Forecast (2017-2032)
5.4 Japan Food Allergy Epidemiology Forecast (2017-2032)
6 Food Allergy Market Overview - 7MM
6.1 Food Allergy Market Historical Value (2017-2023)
6.2 Food Allergy Market Forecast Value (2024-2032)
7 Food Allergy Market Landscape - 7MM
7.1 Food Allergy Therapeutics Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Food Allergy Therapeutics Product Landscape
7.2.1 Analysis by Products
7.2.2 Analysis by Indications
7.2.3 Analysis by Route of Administration
8 Food Allergy Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Food Allergy Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Food Allergy Market Segmentation - 7MM
11.1 Food Allergy Market by Food Source
11.1.1 Market Overview
11.1.2 Dairy Products
11.1.3 Poultry Product
11.1.4 Tree Nuts
11.1.5 Peanuts
11.1.6 Shellfish
11.1.7 Wheat
11.1.8 Soy
11.1.9 Others
11.2 Food Allergy Market by Symptoms
11.2.1 Market Overview
11.2.2 Anaphylaxis
11.2.3 Atopic Dermatitis
11.2.4 Others
11.3 Food Allergy Market by Diagnosis Test
11.3.1 Skin-Prick Tests
11.3.2 Blood Test
11.3.3 Elimination Diet
11.3.4 Oral Food Challenge
11.3.5 Others
11.4 Food Allergy Market by Treatment Type
11.4.1 Market Overview
11.4.2 Epinephrine
11.4.3 Oral Immunotherapy
11.4.4 Antihistamines
11.4.5 Others
11.5 Food Allergy Market by Region
11.5.1 Market Overview
11.5.2 United States
11.5.3 EU-4 and the United Kingdom
11.5.3.1 Germany
11.5.3.2 France
11.5.3.3 Italy
11.5.3.4 Spain
11.5.3.5 United Kingdom
11.5.4 Japan
12 United States Food Allergy Market
12.1 Food Allergy Market Historical Value (2017-2023)
12.2 Food Allergy Market Forecast Value (2024-2032)
12.3 Food Allergy Market by Disease Type
12.4 Food Allergy Market by Treatment Type
13 EU-4 and United Kingdom Food Allergy Market
13.1 Food Allergy Market Historical Value (2017-2023)
13.2 Food Allergy Market Forecast Value (2024-2032)
13.3 Germany Food Allergy Market Overview
13.3.1 Food Allergy Market by Disease Type
13.3.2 Food Allergy Market by Treatment Type
13.4 France Food Allergy Market Overview
13.4.1 Food Allergy Market by Disease Type
13.4.2 Food Allergy Market by Treatment Type
13.5 Italy Food Allergy Market Overview
13.5.1 Food Allergy Market by Disease Type
13.5.2 Food Allergy Market by Treatment Type
13.6 Spain Food Allergy Market Overview
13.6.1 Food Allergy Market by Disease Type
13.6.2 Food Allergy Market by Treatment Type
13.7 United Kingdom Food Allergy Market Overview
13.7.1 Food Allergy Market by Disease Type
13.7.2 Food Allergy Market by Treatment Type
14 Japan Food Allergy Market
14.1 Food Allergy Market Historical Value (2017-2023)
14.2 Food Allergy Market Forecast Value (2024-2032)
14.2.1 Food Allergy Market by Disease Type
14.2.2 Food Allergy Market by Treatment Type
15 Patent Analysis
15.1 Analysis by Type of Patent
15.2 Analysis by Publication year
15.3 Analysis by Issuing Authority
15.4 Analysis by Patent Age
15.5 Analysis by CPC Analysis
15.6 Analysis by Patent Valuation
15.7 Analysis by Key Players
16 Grants Analysis
16.1 Analysis by year
16.2 Analysis by Amount Awarded
16.3 Analysis by Issuing Authority
16.4 Analysis by Grant Application
16.5 Analysis by Funding Institute
16.6 Analysis by NIH Departments
16.7 Analysis by Recipient Organization
17 Clinical Trials Analysis
17.1 Analysis by Trial Registration Year
17.2 Analysis by Trial Status
17.3 Analysis by Trial Phase
17.4 Analysis by Therapeutic Area
17.5 Analysis by Geography
18 Funding Analysis
18.1 Analysis by Funding Instances
18.2 Analysis by Type of Funding
18.3 Analysis by Funding Amount
18.4 Analysis by Leading Players
18.5 Analysis by Leading Investors
18.6 Analysis by Geography
19 Partnership and Collaborations Analysis
19.1 Analysis by Partnership Instances
19.2 Analysis by Type of Partnership
19.3 Analysis by Leading Players
19.4 Analysis by Geography
20 Supplier Landscape
20.1 Pfizer Inc.
20.1.1 Financial Analysis
20.1.2 Product Portfolio
20.1.3 Demographic Reach and Achievements
20.1.4 Mergers and Acquisition
20.1.5 Certifications
20.2 GlaxoSmithKline plc
20.2.1 Financial Analysis
20.2.2 Product Portfolio
20.2.3 Demographic Reach and Achievements
20.2.4 Mergers and Acquisition
20.2.5 Certifications
20.3 Novartis AG
20.3.1 Financial Analysis
20.3.2 Product Portfolio
20.3.3 Demographic Reach and Achievements
20.3.4 Mergers and Acquisition
20.3.5 Certifications
20.4 Mylan N.V.
20.4.1 Financial Analysis
20.4.2 Product Portfolio
20.4.3 Demographic Reach and Achievements
20.4.4 Mergers and Acquisition
20.4.5 Certifications
20.5 Teva Pharmaceutical Industries
20.5.1 Financial Analysis
20.5.2 Product Portfolio
20.5.3 Demographic Reach and Achievements
20.5.4 Mergers and Acquisition
20.5.5 Certifications
20.6 Sanofi
20.6.1 Financial Analysis
20.6.2 Product Portfolio
20.6.3 Demographic Reach and Achievements
20.6.4 Mergers and Acquisition
20.6.5 Certifications
20.7 Boehringer Ingelheim International GmbH
20.7.1 Financial Analysis
20.7.2 Product Portfolio
20.7.3 Demographic Reach and Achievements
20.7.4 Mergers and Acquisition
20.7.5 Certifications
20.8 AstraZeneca
20.8.1 Financial Analysis
20.8.2 Product Portfolio
20.8.3 Demographic Reach and Achievements
20.8.4 Mergers and Acquisition
20.8.5 Certifications
20.9 Johnson & Johnson Private Limited
20.9.1 Financial Analysis
20.9.2 Product Portfolio
20.9.3 Demographic Reach and Achievements
20.9.4 Mergers and Acquisition
20.9.5 Certifications
20.10 Bayer AG
20.10.1 Financial Analysis
20.10.2 Product Portfolio
20.10.3 Demographic Reach and Achievements
20.10.4 Mergers and Acquisition
20.10.5 Certifications
21 Food Allergy Market - Distribution Model (Additional Insight)
21.1 Overview
21.2 Potential Distributors
21.3 Key Parameters for Distribution Partner Assessment
22 Key Opinion Leaders (KOL) Insights (Additional Insight)
23 Company Competitiveness Analysis (Additional Insight)
23.1 Very Small Companies
23.2 Small Companies
23.3 Mid-Sized Companies
23.4 Large Companies
23.5 Very Large Companies
24 Payment Methods (Additional Insight)
24.1 Government Funded
24.2 Private Insurance
24.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Mylan N.V.
  • Teva Pharmaceutical Industries
  • Sanofi
  • Boehringer Ingelheim International GmbH
  • AstraZeneca
  • Johnson & Johnson Private Limited
  • Bayer AG

Methodology

Loading
LOADING...

Table Information